Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19188184 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed p53 Synthetic Long Peptides Vaccine With Cyclophosphamide for Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: P53-SLP vaccine;   Drug: Cyclophosphamide

Indicates status has not been verified in more than two years